← All FR Documents
Notice

Notice of Closed Meeting

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 2704
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, Centers for Disease Control and Prevention. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-00487
FR Citation90 FR 2704
TypeNotice
PublishedJan 13, 2025
Effective Date-
RIN-
Docket ID-
Pages2704–2704 (1 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (376 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>Centers for Disease Control and Prevention</SUBAGY> <SUBJECT>Notice of Closed Meeting</SUBJECT> Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, pursuant to Public Law 92-463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <E T="03">Name of Committee:</E> Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA-OH-24-002, Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21); RFA-OH-24-003, Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Applications with Responders Accepted); RFA-OH-24-004, World Trade Center Health Program Mentored Research Scientist Career Development Award (K01); and RFA-OH-25-001, Exploratory/Developmental Research for World Trade Center Health Program Evidence-based Strategies to Improve Treatment Effectiveness, Diagnostic Practices, and Program Evaluation (R21). <E T="03">Dates and Times:</E> February 25, 2025, 9 a.m.-5 p.m., EST; and February 26, 2025, 9 a.m.-12 p.m., EST. <E T="03">Place:</E> Courtyard by Marriott Atlanta Decatur Downtown/Emory, 130 Clairemont Avenue, Decatur, Georgia 30030. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">For Further Information Contact:</E> Laurel Garrison, M.P.H., Scientific Review Officer, Office of Extramural Coordination and Special Projects, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 5555 Ridge Avenue, Cincinnati, Ohio 45213. Telephone: (513) 533-8324; Email: <E T="03">LGarrison@cdc.gov.</E> The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign <E T="04">Federal Register</E> notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. <SIG> <NAME>Kalwant Smagh,</NAME> Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. </SIG> <FRDOC>[FR Doc. 2025-00487 Filed 1-10-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.